SecBot SecBot

Gene Synthesis Safety and Security Act

S. 2356 Sen. John Hickenlooper (D-CO) In committee
Bill text PDF
  1. Introduced Jul 18
  2. Committee Jul 18
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jul 18, 2023Next: Senate vote
1198d ago Jul 18, 2023: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 1 filing
Subscribe to see spend
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe

Summary

Gene Synthesis Safety and Security Act

Full summary2 paragraphs

This bill requires the Department of Health and Human Services (HHS) to update guidance to address the potential misuse of gene synthesis products (i.e., manufactured genetic products) to obtain biological agents or toxins of concern.

The guidance must include recommendations relating to screening protocols, recordkeeping, technological safeguards, and other specified information. HHS must evaluate the current landscape of gene synthesis manufacturers and related technology to inform the guidance. HHS must also solicit public input to develop a list of genetic sequences of concern.

Library of Congress summary, Jul 18, 2023

Summary versions
  • Introduced in SenateJul 18, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.